Andrew Perry - Net Worth and Insider Trading
Andrew Perry Net Worth
The estimated net worth of Andrew Perry is at least $253,433 dollars as of 2024-06-05. Andrew Perry is the Chief Commercial Officer of G1 Therapeutics Inc and owns about 78,951 shares of G1 Therapeutics Inc (GTHX) stock worth over $253,433. Details can be seen in Andrew Perry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew Perry has not made any transactions after 2024-05-13 and currently still holds the listed stock(s).
Transaction Summary of Andrew Perry
Andrew Perry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Perry owns 1 companies in total, including G1 Therapeutics Inc (GTHX) .
Click here to see the complete history of Andrew Perry’s form 4 insider trades.
Insider Ownership Summary of Andrew Perry
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-05-13 | Chief Commercial Officer |
Andrew Perry Latest Holdings Summary
Andrew Perry currently owns a total of 1 stock. Andrew Perry owns 78,951 shares of G1 Therapeutics Inc (GTHX) as of May 13, 2024, with a value of $253,433.
Latest Holdings of Andrew Perry
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-05-13 | 78,951 | 3.21 | 253,433 |
Holding Weightings of Andrew Perry
Andrew Perry Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Perry has made a total of 4 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 8,151 shares on May 13, 2024, which brought Andrew Perry around $39,043.
Insider Trading History of Andrew Perry
- 1
Andrew Perry Trading Performance
Andrew Perry Ownership Network
Andrew Perry Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Andrew Perry is the Chief Commercial Officer of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include General Counsel Monica R. Thomas , Chief Financial Officer John V. Umstead , and Chief Business Officer Mark Avagliano .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Andrew Perry made 4 insider transaction in G1 Therapeutics Inc (GTHX) with a net sale of 11,739. Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,059 shares made by Rajesh Malik , a net sale of 122,272 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,620 shares made by Terry L Murdock .
In summary, during the past 3 months, insiders sold 90,386 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 90,386 shares. During the past 18 months, 325,925 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 325,925 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Andrew Perry Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Perry. You might contact Andrew Perry via mailing address: C/o G1 Therapeutics, Inc., 700 Park Offices Drive, Suite 200, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
